Oncology Institute (TOI) Competitors $1.14 +0.03 (+2.70%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.21 +0.07 (+5.79%) As of 03/28/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI vs. PSNL, VMD, DCGO, LFMD, AIRS, SERA, BDSX, QIPT, CORBF, and EUDAShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Personalis (PSNL), Viemed Healthcare (VMD), DocGo (DCGO), LifeMD (LFMD), AirSculpt Technologies (AIRS), Sera Prognostics (SERA), Biodesix (BDSX), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), and EUDA Health (EUDA). These companies are all part of the "healthcare" industry. Oncology Institute vs. Personalis Viemed Healthcare DocGo LifeMD AirSculpt Technologies Sera Prognostics Biodesix Quipt Home Medical Global Cord Blood EUDA Health Personalis (NASDAQ:PSNL) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, community ranking, earnings, risk, institutional ownership, profitability and dividends. Do institutionals & insiders believe in PSNL or TOI? 61.9% of Personalis shares are owned by institutional investors. Comparatively, 36.9% of Oncology Institute shares are owned by institutional investors. 4.1% of Personalis shares are owned by company insiders. Comparatively, 9.5% of Oncology Institute shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has preferable valuation and earnings, PSNL or TOI? Oncology Institute has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPersonalis$84.61M3.78-$108.30M-$1.37-2.64Oncology Institute$393.41M0.22-$83.07M-$0.71-1.61 Does the media prefer PSNL or TOI? In the previous week, Oncology Institute had 16 more articles in the media than Personalis. MarketBeat recorded 17 mentions for Oncology Institute and 1 mentions for Personalis. Personalis' average media sentiment score of 1.89 beat Oncology Institute's score of -0.08 indicating that Personalis is being referred to more favorably in the media. Company Overall Sentiment Personalis Very Positive Oncology Institute Neutral Which has more risk and volatility, PSNL or TOI? Personalis has a beta of 1.73, indicating that its stock price is 73% more volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Do analysts rate PSNL or TOI? Personalis presently has a consensus price target of $7.80, indicating a potential upside of 115.47%. Given Personalis' stronger consensus rating and higher probable upside, research analysts plainly believe Personalis is more favorable than Oncology Institute.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Personalis 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in PSNL or TOI? Personalis received 120 more outperform votes than Oncology Institute when rated by MarketBeat users. Likewise, 68.13% of users gave Personalis an outperform vote while only 66.67% of users gave Oncology Institute an outperform vote. CompanyUnderperformOutperformPersonalisOutperform Votes12468.13% Underperform Votes5831.87% Oncology InstituteOutperform Votes466.67% Underperform Votes233.33% Is PSNL or TOI more profitable? Oncology Institute has a net margin of -17.63% compared to Personalis' net margin of -104.52%. Personalis' return on equity of -66.07% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Personalis-104.52% -66.07% -41.34% Oncology Institute -17.63%-186.83%-34.58% SummaryPersonalis beats Oncology Institute on 10 of the 18 factors compared between the two stocks. Remove Ads Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$86.14M$1.03B$5.63B$7.84BDividend YieldN/AN/A4.57%4.01%P/E Ratio-1.4617.0023.3318.67Price / Sales0.221.04387.5490.66Price / CashN/A36.0138.1634.64Price / Book1.488.366.894.23Net Income-$83.07M-$52.07M$3.20B$247.15M7 Day Performance14.43%-4.56%-2.98%-2.18%1 Month Performance33.79%-16.48%1.63%-5.68%1 Year Performance-27.85%-27.24%9.44%-0.74% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute0.349 of 5 stars$1.14+2.7%N/A-27.8%$86.14M$393.41M-1.46660Earnings ReportPSNLPersonalis4.217 of 5 stars$3.84+7.9%$7.80+103.1%+143.0%$338.93M$84.61M-2.29400Gap UpVMDViemed Healthcare1.1296 of 5 stars$7.30+0.8%N/A-22.9%$288.51M$224.26M27.04630News CoveragePositive NewsDCGODocGo3.0583 of 5 stars$2.77+3.7%$4.89+76.6%-34.7%$282.49M$616.56M9.892,920Short Interest ↓LFMDLifeMD1.8475 of 5 stars$6.10+8.9%$11.43+87.4%-47.0%$271.96M$212.45M-9.53230Short Interest ↑AIRSAirSculpt Technologies1.2704 of 5 stars$2.74+3.8%$5.00+82.5%-62.7%$160.50M$180.35M-19.57240Short Interest ↑High Trading VolumeSERASera Prognostics0.6668 of 5 stars$4.14+9.2%N/A-61.1%$139.82M$77,000.00-4.18120BDSXBiodesix2.8701 of 5 stars$0.83-1.9%$2.95+255.2%-53.1%$121.24M$71.32M-2.13220Short Interest ↑QIPTQuipt Home Medical2.6317 of 5 stars$2.34-1.3%$6.25+167.1%-46.9%$100.83M$244.72M-13.76800Positive NewsCORBFGlobal Cord BloodN/A$0.80flatN/A-40.7%$97.24M$196.12M0.001,200Positive NewsEUDAEUDA Health0.4375 of 5 stars$3.93-3.2%N/A+100.0%$96.79M$3.81M0.002 Remove Ads Related Companies and Tools Related Companies Personalis Alternatives Viemed Healthcare Alternatives DocGo Alternatives LifeMD Alternatives AirSculpt Technologies Alternatives Sera Prognostics Alternatives Biodesix Alternatives Quipt Home Medical Alternatives Global Cord Blood Alternatives EUDA Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOI) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TOI Stock Free TOI Stock Alerts